Sign in
4

Changes in Ownership

Cullinan Therapeutics, Inc. Filed Acc 0001209191-21-056409

Director sold 15,401 shares at an average $29.17 ($449,174)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
GADICKE ANSBERT Director 2021-09-14 Sale −982 $29.17 $28,645 245,871 D
GADICKE ANSBERT Director 2021-09-14 Sale −7,106 $29.17 $207,282 7,657,817 I
GADICKE ANSBERT Director 2021-09-15 Sale −888 $29.16 $25,894 244,983 D
GADICKE ANSBERT Director 2021-09-15 Sale −6,425 $29.16 $187,353 7,651,392 I
Open-market sales · 15,401 sh · avg $29.17 · $449,174
Loading xslF345X03/doc4.xml…